Terbutaline sulfate Tablets Rx
Generic Name and Formulations:
Terbutaline sulfate 2.5mg, 5mg; scored tabs.
Various generic manufacturers
Indications for Terbutaline sulfate Tablets:
Asthma. Chronic bronchitis. Emphysema.
12–15yrs: 2.5mg 3 times daily at 6 hour intervals. >15yrs: 2.5–5mg 3 times daily at 6 hour intervals.
Not for management of preterm labor. Avoid excessive use. Diabetes. Cardiac disease. Hypertension. Hyperthyroidism. Seizure disorders. If subject to hypokalemia, monitor potassium. Pregnancy (Cat.B). Nursing mothers.
Avoid other sympathomimetics (except aerosol bronchodilators), MAOIs, tricyclics. Antagonized by β-blockers.
Tachycardia, palpitations, nervousness, tremor, headache, drowsiness, nausea.
Formerly known under the brand names Brethine, Bricanyl.
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- The Caregivers' Cancer Journey
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Fertility Preservation in Hodgkin's Lymphoma Patients That Undergo Targeted Molecular Therapies: An Important Step Forward From the Chemotherapy Era
- Survey of ACEP Councilors Reveals NP, PA Staffing Models, Practice Patterns Vary
- Breath Analysis May Be an Effective Diagnostic for Pancreatic Cancer
- Genetic Susceptibility to Pancreatic Cancer Linked to 6 Specific Gene Mutations
- Dinner Hour and Sleep Habits Affect Risk of Breast, Prostate Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|